Othman NA, Shaker OG, Elshenawy HM, Abd-Elmoniem W, Eldin AM, Fakhr MY. The effect of diode laser and
topical steroid on serum level of TNF-alpha in oral lichen planus
patients. J Clin Exp Dent.
2016;8(5):e566-70.
doi:10.4317/jced.52665
References
|
1. McCartan
BE, Healy CM. The reported prevalence of oral lichen
planus: a review and critique. J Oral Pathol Med. 2008;37:447-53. |
|
|
|
|
|
2. Mostafa
B, Ahmed E. Prevalence of oral lichen planus among
a sample of the Egyptian population. Clin Exp Dent.
2015;7:7-12. |
|
|
|
|
|
3. Sousa FA, Rosa LE. Oral
lichen planus: Clinical and histopathological
considerations. Bras J Otorhinolaryngol. 2008;74:248-92. PMid:18568210 |
|
|
|
|
|
4. Sugerman
PB, Savage NW, Walsh LJ, Zhao ZZ, Bigby M. The
pathogenesis of oral lichen planus. Crit Rev Oral Biol Med. 2002;13:350-65. |
|
|
|
|
|
5. Roopashree
MR, Gondhalekar RV, Shashikanth
MC, George J, Thippeswamy SH, Shukla
A. Pathogenesis of oral lichen planus--a review. J
Oral Pathol Med. 2010;39:729-34. |
|
|
|
|
|
6. Ismail SB, Kumar SK, Zain RB. Oral lichen planus and
lichenoid reactions: etiopathogenesis,
diagnosis, management and malignant transformation. J Oral Sci. 2007;49:89-106. |
|
|
|
|
|
7. Thongprasom
K, Dhanuthai K, Sarideechaigul
W, Chaiyarit P, Chaimusig M. Expression of TNF-alpha in oral lichen
planus treated with fluocinolone
acetonide 0.1%. J Oral Pathol
Med. 2006;35:161-6. |
|
|
|
|
|
8. Farhi
D, Dupin N. Pathophysiology,
etiologic factors, and clinical management of oral lichen planus,
part I: facts and controversies. Clin Dermatol. 2010;28:100-8. |
|
|
|
|
|
9. Ding G, Wang W, Liu Y,
Zhang C, Wang S. Mesenchymal stem cell
transplantation: a potential therapy for oral lichen planus.
Med Hypotheses. 2011;76:322-4. |
|
|
|
|
|
10. Valera FC, Queiroz R, Scrideli C, Tone LG,
Anselmo-Lima WT. Evaluating budesonide
efficacy in nasal polyposis and predicting the
resistance to treatment. Clin Exp Allergy. 2009;39:81-8. |
|
|
|
|
|
11. Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am J Clin Dermatol. 2002;3:141-7. |
|
|
|
|
|
12.
Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid
resistance: clinical aspects, molecular mechanisms, and implications of a
rare genetic disorder. J Clin Endocrinol
Metab. 2008;93:1563-72. |
|
|
|
|
|
13. Passeron
T, Zakaria W, Ostovari N,
Mantoux F, Lacour JP, Ortonne JP. Treatment of erosive oral lichen planus by the 308 nm excimer
laser. Lasers Surg Med. 2004;34:205. |
|
|
|
|
|
14. Thongprasom
K, Luangjarmekorn L, Sererat
T, Taweesap W. Relative efficacy of fluocinolone acetonide compared
with triamcinolone acetonide
in treatment of oral lichen planus. J Oral Pathol Med. 1992;21:456-8. |
|
|
|
|
|
15. Jajarm
HH, Falaki F, Mahdavi O.
A comparative pilot study of low intensity laser versus topical
corticosteroids in the treatment of erosive-atrophic oral lichen planus. Photomed Laser Surg. 2011;29:421-5. |
|
|
|
|
|
16. Cafaro
A, Arduino PG, Massolini
G, Romagnoli E, Broccoletti
R. Clinical evaluation of the efficiency of low-level laser therapy for oral
lichen planus: a prospective case series. Lasers Med Sci. 2014;29:185-90. |
|
|
|
|
|
17. Eisen
D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V Oral lichen planus:
clinical features and management. Oral Dis.
2005;11:338-49. |
|
|
|
|
|
18. van der Hem PS, Egges M, van der Wal JE, Roodenburg
JL. CO2 laser evaporation of oral lichen planus. Int J Oral Maxillofac Surg.
2008;37:630-3. |
|
|
|
|
|
19. Trehan
M, Taylor CR. Low-dose excimer 308-nm laser for the
treatment of oral lichen planus. Arch Dermatol. 2004;140:415-20. |
|
|
|
|
|
20. Cafaro
A, Albanese G, Arduino PG, Mario C, Massolini G, Mozzati M, et al.
Effect of low-level laser irradiation on unresponsive oral lichen planus: early preliminary results in 13 patients. Photomed Laser Surg. 2010;28 Suppl 2:S99-103. |
|
|
|
|
|
21. Walsh LJ. The current
status of low level laser therapy in dentistry. Part 1. Soft tissue applications.
Aust Dent J. 1997;42:247-4. |
|
|
|
|
|
22.
Lins RD, Dantas EM, Lucena KC, Catão
MH, Granville-Garcia AF, Carvalho Neto LG. Biostimulation effects of low-power laser in the repair process. An Bras Dermatol. 2010;85:849-55. |
|
|
|
|
|
23. Mahdavi
O, Boostani N, Jajarm H, Falaki F, Tabesh A. Use of low
level laser therapy for oral lichen planus: report
of two cases. J
Dent (Shiraz). 2013;14:201-4. PMid:24724146 |
|
|
|
|
|
24. Kazancioglu
HO, Erisen M. Comparison of Low-Level Laser Therapy
versus Ozone Therapy in the Treatment of Oral Lichen Planus.
Ann
Dermatol. 2015;27:485-91. |
|
|
|
|
|
25. Bjordal
JM, Johnson MI, Iversen V, Aimbire
F, Lopes-Martins RA. Low-level laser therapy in acute pain: a systematic
review of possible mechanisms of action and clinical effects in randomized
placebo-controlled trials. Photomed Laser Surg. 2006;24:158-68. |
|
|
|
|
|
26.
Cavalcanti TM, Almeida-Barros RQ, Catão MH, Feitosa AP, Lins RD. Knowledge of
the physical properties and interaction of laser with biological tissue in
dentistry. An Bras Dermatol. 2011;86:955-60. |
|
27. Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE. Glucocorticosteroid
action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol. 1991;9:413-23.
PMid:1934694